E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck

NCT02630264 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Endostatins
DRUG: Paclitaxel injection
DRUG: Cisplatin injection

Sponsor

Guangzhou Double Bioproducts Co., Ltd